With the rise of Janus kinase (JAK) and Signal Transducer and Activator of Transcription (STAT) inhibitor use in dermatologic conditions, there has been increasing hope in treating extensive and difficult-to-treat inflammatory cutaneous conditions. Today we report a case of oral lichen planus successfully treated with an oral JAK1 inhibitor, upadacitinib. This case had been unresponsive by several standard methods but responded with 70% improvement within 1 month when treated with upadacitinib. J Drugs Dermatol. 2024;23(4):7859. doi:10.36849/JDD.7859e .
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.36849/JDD.7859 | DOI Listing |
Publication Analysis
Top Keywords
oral lichen
8
lichen planus
8
planus treated
8
treated upadacitinib
4
upadacitinib rise
4
rise janus
4
janus kinase
4
kinase jak
4
jak signal
4
signal transducer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!